Additionally, our results corroborate the findings of González et al., who identified elevated IL-6 as a marker indicative of metabolic abnormalities among PCOS patients, reinforcing the association between heightened IL-6 levels and metabolic dysregulation within this patient population [15]. This evidence concerns the gene IL6 and polycystic ovary syndrome.